Franco Oreste Ranelletti
Franco Oreste Ranelletti
Professore di Istologia, UniversitÓ Cattolica
Verified email at rm.unicatt.it
TitleCited byYear
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential
S Caltagirone, C Rossi, A Poggi, FO Ranelletti, PG Natali, M Brunetti, ...
International Journal of Cancer 87 (4), 595-600, 2000
5422000
Class III β-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients
S Mozzetti, C Ferlini, P Concolino, F Filippetti, G Raspaglio, S Prislei, ...
Clinical Cancer Research 11 (1), 298-305, 2005
4112005
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
B Rocca, P Secchiero, G Ciabattoni, FO Ranelletti, L Catani, L Guidotti, ...
Proceedings of the National Academy of Sciences 99 (11), 7634-7639, 2002
3782002
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target
G Scambia, FO Ranelletti, PB Panici, R De Vincenzo, G Bonanno, ...
Cancer chemotherapy and pharmacology 34 (6), 459-464, 1994
3351994
n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE 2 induced ERK-1 and -2 and HIF-1α induction pathway
G Calviello, F Di Nicuolo, S Gragnoli, E Piccioni, S Serini, N Maggiano, ...
Carcinogenesis 25 (12), 2303-2310, 2004
2842004
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients
G Ferrandina, L Lauriola, MG Distefano, GF Zannoni, M Gessi, F Legge, ...
Journal of Clinical Oncology 20 (4), 973-981, 2002
2432002
Growth‐inhibitory effect of quercetin and presence of type‐II estrogen‐binding sites in human colon‐cancer cell lines and primary colorectal tumors
FO Ranelletti, R Ricci, LM Larocca, N Maggiano, A Capelli, G Scambia, ...
International Journal of Cancer 50 (3), 486-492, 1992
1941992
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients
G Ferrandina, L Lauriola, GF Zannoni, A Fagotti, F Fanfani, F Legge, ...
Annals of Oncology 13 (8), 1205-1211, 2002
1922002
Quercetin inhibits p21‐RAS expression in human colon cancer cell lines and in primary colorectal tumors
FO Ranelletti, N Maggiano, FG Serra, R Ricci, LM Larocca, P Lanza, ...
International journal of cancer 85 (3), 438-445, 2000
1902000
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance
C Ferlini, G Raspaglio, S Mozzetti, M Distefano, F Filippetti, E Martinelli, ...
Molecular pharmacology 64 (1), 51-58, 2003
1642003
Thymus changes in anti-MuSK-positive and-negative myasthenia gravis
L Lauriola, F Ranelletti, N Maggiano, M Guerriero, C Punzi, F Marsili, ...
Neurology 64 (3), 536-538, 2005
1622005
Cyclooxygenase‐2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome
G Ferrandina, F Legge, FO Ranelletti, GF Zannoni, N Maggiano, ...
Cancer: Interdisciplinary International Journal of the American Cancerá…, 2002
1542002
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells
G Scambia, FO Ranelletti, PB Panici, M Piantelli, G Bonanno, ...
British journal of cancer 62 (6), 942-946, 1990
1521990
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites
G Scambia, FO Ranelletti, PB Panici, M Piantelli, G Bonanno, ...
Cancer chemotherapy and pharmacology 28 (4), 255-258, 1991
1451991
β-Carotene at high concentrations induces apoptosis by enhancing oxy-radical production in human adenocarcinoma cells
P Palozza, G Calviello, S Serini, N Maggiano, P Lanza, FO Ranelletti, ...
Free Radical Biology and Medicine 30 (9), 1000-1007, 2001
1292001
Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines
P Palozza, M Colangelo, R Simone, A Catalano, A Boninsegna, P Lanza, ...
Carcinogenesis 31 (10), 1813-1821, 2010
1282010
Docosahexaenoic acid induces proteasome-dependent degradation of β-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2
G Calviello, F Resci, S Serini, E Piccioni, A Toesca, A Boninsegna, ...
Carcinogenesis 28 (6), 1202-1209, 2007
1232007
Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer
S Caltagirone, FO Ranelletti, A Rinelli, N Maggiano, A Colasante, ...
American journal of respiratory cell and molecular biology 17 (1), 51-59, 1997
1221997
Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil
G Calviello, F Di Nicuolo, S Serini, E Piccioni, A Boninsegna, N Maggiano, ...
Cancer chemotherapy and pharmacology 55 (1), 12-20, 2005
1202005
In vitro evaluation of newly developed chalcone analogues in human cancer cells
R De Vincenzo, C Ferlini, M Distefano, C Gaggini, A Riva, E Bombardelli, ...
Cancer chemotherapy and pharmacology 46 (4), 305-312, 2000
1182000
The system can't perform the operation now. Try again later.
Articles 1–20